Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

N. Thatcher, Fred R. Hirsch, Alexander Valerievich Luft et al. · The Lancet Oncology · 2015

Cited by 479 works. doi:10.1016/s1470-2045(15)00021-2

Authors

References